 |
Previous Article | Next Article 
Journal of Neuroscience, Vol 13, 1035-1044, Copyright © 1993 by Society for Neuroscience
Modulation of dopamine efflux in the striatum following cholinergic stimulation of the substantia nigra in intact and pedunculopontine tegmental nucleus-lesioned rats
CD Blaha and P Winn
Department of Psychology, University of British Columbia, Vancouver, Canada.
The effects of microinjections of cholinergic agents into the substantia
nigra pars compacta on dopamine (DA) efflux in the anterior dorsomedial
striatum of urethane-anesthetized rats were investigated using in vivo
chronoamperometry and intracerebral microdialysis techniques. A
dose-dependent augmentation of DA efflux as evidenced by increases in the
chronoamperometric signals was observed in the striatum following nigral
microinjections of the cholinergic agonists nicotine or carbachol.
Enhancing extracellular concentrations of ACh in the substantia nigra by
intranigral infusions of the cholinesterase inhibitor neostigmine also
resulted in an increase in the chronoamperometric signal corresponding to
DA overflow in the striatum. These stimulatory effects of neostigmine on DA
efflux in the striatum were confirmed using in vivo microdialysis. Compared
to sham-operated control animals, quinolinic acid lesions of the
pedunculopontine tegmental nucleus (PPTg) resulted in an attenuation of the
stimulatory effects of intranigral neostigmine on DA efflux in the
striatum. In contrast, these treatments resulted in an enhancement of
striatal DA efflux in response to nigral infusions of the direct ACh
receptor agonist nicotine. Combined, these data suggest that PPTg
cholinergic neurons are indirectly involved in regulating the activity of
the striatum by modulating the activity of DA neurons in the substantia
nigra of the rat.
This article has been cited by other articles:

|
 |

|
 |
 
K.-i. Okada, K. Toyama, Y. Inoue, T. Isa, and Y. Kobayashi
Different Pedunculopontine Tegmental Neurons Signal Predicted and Actual Task Rewards
J. Neurosci.,
April 15, 2009;
29(15):
4858 - 4870.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Avale, P. Faure, S. Pons, P. Robledo, T. Deltheil, D. J. David, A. M. Gardier, R. Maldonado, S. Granon, J.-P. Changeux, et al.
Interplay of {beta}2* nicotinic receptors and dopamine pathways in the control of spontaneous locomotion
PNAS,
October 14, 2008;
105(41):
15991 - 15996.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Huang, C. Tang, A. Feigin, M. Lesser, Y. Ma, M. Pourfar, V. Dhawan, and D. Eidelberg
Changes in network activity with the progression of Parkinson's disease
Brain,
July 1, 2007;
130(7):
1834 - 1846.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Michel, J. M. Robillard, and L.-E. Trudeau
Regulation of rat mesencephalic GABAergic neurones through muscarinic receptors
J. Physiol.,
April 15, 2004;
556(2):
429 - 445.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. S. Middleton, W. A. Cass, and L. P. Dwoskin
Nicotinic Receptor Modulation of Dopamine Transporter Function in Rat Striatum and Medial Prefrontal Cortex
J. Pharmacol. Exp. Ther.,
January 1, 2004;
308(1):
367 - 377.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Laviolette, T. O. Alexson, and D. van der Kooy
Lesions of the Tegmental Pedunculopontine Nucleus Block the Rewarding Effects and Reveal the Aversive Effects of Nicotine in the Ventral Tegmental Area
J. Neurosci.,
October 1, 2002;
22(19):
8653 - 8660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Yeomans, J. Takeuchi, M. Baptista, D. D. Flynn, K. Lepik, J. Nobrega, J. Fulton, and M. R. Ralph
Brain-Stimulation Reward Thresholds Raised by an Antisense Oligonucleotide for the M5 Muscarinic Receptor Infused near Dopamine Cells
J. Neurosci.,
December 1, 2000;
20(23):
8861 - 8867.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. d. M. Arroyo-Jimenez, J.-P. Bourgeois, L. M. Marubio, A.-M. Le Sourd, O. P. Ottersen, E. Rinvik, A. Fairen, and J.-P. Changeux
Ultrastructural Localization of the alpha 4-Subunit of the Neuronal Acetylcholine Nicotinic Receptor in the Rat Substantia Nigra
J. Neurosci.,
August 1, 1999;
19(15):
6475 - 6487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Menzaghi, K. T. Whelan, V. B. Risbrough, T. S. Rao, and G. K. Lloyd
Interactions between a Novel Cholinergic Ion Channel Agonist, SIB-1765F and L-DOPA in the Reserpine Model of Parkinson's Disease in Rats
J. Pharmacol. Exp. Ther.,
January 1, 1997;
280(1):
393 - 401.
[Abstract]
[Full Text]
|
 |
|
|

|